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Abstract
Background: We wanted to quantify HLA-A and -B phenotype and haplotype frequencies in
Alabama index patients with common variable immunodeficiency (CVID) and selective IgG subclass
deficiency (IgGSD), and in control subjects.
Methods:  Phenotypes were detected using DNA-based typing (index cases) and
microlymphocytotoxicity typing (controls).
Results: A and B phenotypes were determined in 240 index cases (114 CVID, 126 IgGSD) and
1,321 controls and haplotypes in 195 index cases and 751 controls. Phenotyping revealed that the
"uncorrected" frequencies of A*24, B*14, B*15, B*35, B*40, B*49, and B*50 were significantly
greater in index cases, and frequencies of B*35, B*58, B*62 were significantly lower in index cases.
After Bonferroni corrections, the frequencies of phenotypes A*24, B*14, and B*40 were
significantly greater in index cases, and the frequency of B*62 was significantly lower in index cases.
The most common haplotypes in index cases were A*02-B*44 (frequency 0.1385), A*01-B*08
(frequency 0.1308), and A*03-B*07 (frequency 0.1000), and the frequency of each was significantly
greater in index cases than in control subjects ("uncorrected" values of p < 0.0001, 0.0252, and
0.0011, respectively). After performing Bonferroni corrections, however, the frequency of A*02-
B*44 alone was significantly increased in probands (p < 0.0085). Three other haplotypes were also
significantly more frequent in index cases (A*03-B*14, A*31-B*40, and A*32-B*14). The combined
frequencies of three latter haplotypes in index patients and control subjects were 0.0411 and
0.0126, respectively ("uncorrected" value of p < 0.0002; "corrected" value of p = 0.0166). Most
phenotype and haplotype frequencies in CVID and IgGSD were similar. 26.7% of index patients
were HLA-haploidentical with one or more other index patients. We diagnosed CVID or IgGSD
in first-degree or other relatives of 26 of 195 index patients for whom HLA-A and -B haplotypes
had been ascertained; A*01-B*08, A*02-B*44, and A*29-B*44 were most frequently associated
with CVID or IgGSD in these families. We conservatively estimated the combined population
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frequency of CVID and IgGSD to be 0.0092 in adults, based on the occurrence of CVID and IgGSD
in spouses of the index cases.
Conclusions: CVID and IgGSD in adults are significantly associated with several HLA haplotypes,
many of which are also common in the Alabama Caucasian population. Immunoglobulin phenotype
variability demonstrated in index cases and family studies herein suggests that there are multiple
gene(s) on Ch6p or other chromosomes that modify immunoglobulin phenotypes of CVID and
IgGSD. The estimated prevalence of CVID and IgGSD in central Alabama could be reasonably
attributed to the fact that many HLA haplotypes significantly associated with these disorders are
also common in the general population.
Background
Common variable immunodeficiency (CVID) and selec-
tive immunoglobulin G subclass deficiency (IgGSD) are
characterized by subnormal serum concentrations of total
IgG, or by normal serum total IgG concentrations with
deficiency of one or more IgG subclasses, respectively; in
some cases, IgA or IgM levels are also subnormal [1–3].
Most persons are diagnosed to have CVID or IgGSD
because they have increased frequency and severity of
infections due to bacteria and other microbial pathogens
[1,4]. Although a susceptibility locus for these disorders
has not been identified, they often appear to be familial
and to segregate with markers on Ch6p [1,5,6].
The purpose of the present work was to quantify and ana-
lyze the frequencies of HLA-A and -B phenotypes and hap-
lotypes in index cases with CVID and IgGSD in central
Alabama who presented because they had increased fre-
quency or severity of infections, and to compare the
present results to those of control subjects in this geo-
graphic area. We also evaluated the relationships of HLA-
A and -B phenotype frequencies and haplotypes with phe-
notypes defined by serum immunoglobulin concentra-
tions, and we estimated the combined frequency of CVID
and IgGSD in central Alabama based upon the occurrence
of these disorders in the spouses of the present index
cases. The implications of the present results in determin-
ing the hereditary basis and immunoglobulin phenotype
expression of CVID and IgGSD are discussed.
Methods
Selection of Subjects
General Criteria for Selection of Study Subjects
The performance of this work was approved by the Insti-
tutional Review Boards of Brookwood Medical Center and
the University of Alabama at Birmingham, and the Ethical
Principles for Medical Research involving Human Sub-
jects promulgated by the World Medical Association Dec-
laration of Helsinki were followed. All subjects were
adults (≥ 18 years of age) who identified themselves as
Caucasians; each resided in central Alabama. The first per-
sons in respective families diagnosed to have CVID or
IgGSD were designated as index cases. All index persons
were diagnosed in routine medical care in a single com-
munity medical center; none was diagnosed as a conse-
quence of family or population screening. We included all
evaluable index patients diagnosed between November
1991 and June 2002.
CVID and IgGSD Index Cases
Each patient was diagnosed to have CVID or IgGSD defi-
ciency as an adult because he/she had frequent or unusu-
ally severe infections. Each patient had a single, severe or
life-threatening infection that required hospitalization or
four or more infections per year that required antibiotic
therapy for at least two consecutive years. None was
known to have pre-existing isolated IgA deficiency or
other abnormality of immunity. Diagnoses were based on
demonstration of persistent, otherwise unexplained
serum concentrations of immunoglobulins > 2 S.D. below
the corresponding mean levels [1]. Criteria for the diagno-
sis of CVID were: 1) decreased total serum IgG concentra-
tion; and 2) either decreased IgG subclass(es), decreased
serum IgA concentration, or decreased serum IgM concen-
tration [1]. Criteria for the diagnosis of IgGSD were: 1)
normal total serum IgG concentration; and 2) abnormally
low serum concentrations of one or more IgG subclasses;
some patients with IgGSD also had decreased levels of IgA
or IgM levels [1].
We excluded persons of African American descent
because: 1) certain HLA types and haplotypes differ signif-
icantly among Caucasians and African Americans in cen-
tral Alabama [7–10]; 2) in adults, serum concentrations of
immunoglobulins are often greater in persons of sub-
Saharan African descent than in whites [11,12]; and 3)
persons of sub-Saharan descent occur infrequently in
series of CVID or IgGSD patients [4], and such patients are
uncommon in our experience. We also excluded persons
who had isolated deficiencies of IgA or IgM, those with
hypogammaglobulinemia attributable to B-cell neo-
plasms (e.g., B-chronic lymphocytic leukemia, plasma cell
myeloma, macroglobulinemia, or non-Hodgkin's lym-
phoma) or those with markedly increased immunoglobu-
lin loss (e.g., nephrotic syndrome or protein-losing
enteropathy).BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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Control Subjects
Data from 1,321 apparently normal, unrelated Caucasian
adult subjects from Alabama who had undergone HLA-A
and -B phenotype analysis as part of paternity testing were
used to estimate allele and gene frequencies [10,13]. HLA-
A and -B haplotypes were determined in 751 unrelated
Caucasian subjects from Alabama who had undergone
testing to establish paternity [10]. Haplotypes were
assessed from a child and his/her mother or father, and
included in the data set. Preliminary data analysis
revealed that frequencies of the major HLA-A and -B hap-
lotypes observed in the present control subjects were sim-
ilar to those estimated to occur in Caucasians from a large
national bone marrow donor program [14].
Family Members
We diagnosed CVID or IgGSD deficiency in some family
members using the same criteria defined herein for index
patients. These persons presented themselves for evalua-
tion after an index case was diagnosed in their respective
kinships because they also had increased frequency and
severity of bacterial infections. Although other relatives of
index cases were also reported to have increased frequency
and severity of infections or to have some form of anti-
body deficiency, they were not included in the present
study because we did not evaluate them. Screening or
other systematic testing of family members of the present
index cases was beyond the scope of the present study.
Laboratory Methods
Serum concentrations of IgG, IgA, IgM, and IgG subclasses
were measured using standard automated methods before
IgG replacement therapy was initiated. Reference ranges
for serum immunoglobulin concentrations are: total IgG
700 – 1600 mg/dL; IgG1 422 – 1292 mg/dL; IgG2 117 –
747 mg/dL; IgG3 41 – 129 mg/dL; IgG4 1 – 291 mg/dL;
total IgA 70 – 400 mg/dL; and IgM 40 – 230 mg/dL. The
basis of these reference ranges has been reported else-
where [15]. Deficiency of an immunoglobulin class or
subclass was defined by a serum concentration at diagno-
sis that was less than the corresponding lower reference
limit. Measurement of IgA subclasses, IgD, or IgE in serum
was not routinely performed.
HLA -A and -B alleles were detected using low-resolution
DNA-based typing (PCR/sequence-specific oligonucle-
otide probe) in index cases [16]. Control subjects were
tested using the microdroplet lymphocytotoxicity test [8];
subjects were evaluated using antisera that detected allele
assignments described in the 9th International Histocom-
patibility Workshop [17]. Because the levels of resolution
of the DNA-based and serological typing methods we
used are similar, alleles detected by these respective meth-
ods provide concordant allele assignments, with the
exception of B*70 and B*71 that were not detected by
serological methods. HLA typing of family members was
performed to permit assignment of Ch6p haplotypes. In
each index patient in whom a single A or B allele was
detected by DNA-based typing, we verified the allele(s)
and set phase to ascertain haplotypes of the index patient
using HLA analyses of appropriate family members. For
the present analysis, all haplotypes were defined only by
A and B alleles.
Statistical Considerations
A data set that included HLA-A and -B phenotypes in 240
index patients with either CVID or IgGSD and HLA-A and
-B haplotypes in 195 of these 240 index patients was avail-
able. Absolute or "uncorrected" values of A and B pheno-
type frequencies in index cases, A and B haplotype
frequencies, and occurrence of two-haplotype combina-
tions were calculated after enumeration of the raw data.
To correct for the possible occurrence of spurious HLA
antigen and haplotype associations due to multiple com-
parisons, we also computed values of p using the Bonfer-
roni inequality method [18]. "Corrected" values of p are
displayed in tabular form along with "uncorrected" val-
ues. A computer spreadsheet (Excel 2000, Microsoft
Corp., Redmond, WA) and a statistical program (GB-Stat,
v. 8.0 2000, Dynamic Microsystems, Inc., Silver Spring,
MD) were used to perform the present analyses. Means
were compared using a student t-test (two-tail). Frequency
values were compared using chi-square analysis or Fisher's
exact test (one-tail), as appropriate. A value of p < 0.05 was
defined as significant. Only significant values of p are dis-
played, and these are expressed to four significant figures.
Results
General Characteristics of CVID and IgGSD Index Patients
There were approximately equal fractions of index
patients with CVID and IgGSD, respectively (Table 1).
There was a preponderance of women in index patients in
both disorders. The mean ages of patients in CVID and
IgGSD groups were similar. In CVID, the most frequent
pattern of IgG deficiency was that of IgG1 + IgG3 sub-
classes. In persons with IgGSD, isolated IgG3 deficiency
was the most frequent IgG subclass deficiency phenotype
(Table 1). Eight of the present index patients (3 CVID, 5
IgGSD; 2 men, 6 women) also had hemochromatosis
associated with homozygosity for HFE C282Y on Ch6p;
another man had CVID and a hemochromatosis pheno-
type associated with the HFE genotype C282Y/H63D.
Frequencies of HLA-A and -B Phenotypes
Sixteen A phenotypes were detected in 240 index cases
and control subjects (Table 2). The most frequent A phe-
notypes in index cases were A*02 (0.5292), A*01
(0.3458), and A*03 (0.2875). The most frequent A phe-
notypes in controls were A*02 (0.5206), A*01 (0.3397),
and A*03 (0.2739). The phenotype A*24 occurred withBMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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Table 1: Characteristics of Index Patients with CVID and IgGSD.1
Characteristic CVID (n = 114) IgGSD (n = 126)
Men: Women 32: 82 38: 88
Age at Diagnosis, y (range) 54 ± 16 (21 – 87) 51 ± 13 (18 – 89)
Serum Total IgG, mg/dL (range) 527 ± 115 (140 – 697) 953 ± 199 (700 – 1751)
Deficient IgG Subclass(es) Percentage (n) Percentage (n)
1, 3 38.6 (44) 8.7 (11)
1 16.7 (19) 17.5 (22)
1, 2, 3 12.3 (14) 0
3 7.0 (8) 52.4 (66)
1, 2 7.0 (8) 0
1, 3, 4 7.0 (8) 0
1, 4 5.3 (6) 3.2 (4)
2, 3 3.5 (4) 1.6 (2)
1, 2, 3, 4 2.6 (3) 0
2 0.9 (1) 3.2 (4)
1, 2, 4 0.9 (1) 0
4 0 7.9 (10)
3, 4 0 4.8 (6)
2, 3, 4 0 0.8 (1)
Index Patients with Serum IgA Deficiency, % (n) 21.1 (24) 9.5 (12)
Index Patients with Serum IgM Deficiency, % (n) 18.4 (21) 7.9 (10)
1 By definition, all probands with CVID had subnormal serum concentrations of total IgG at diagnosis; mean serum IgG concentrations were signifi-
cantly lower in CVID (p < 0.000.1; two-tail t-test). The percentage of index patients with IgA deficiency was significantly greater in CVID (p = 
0.0293; Chi-square test). The percentage of index patients with IgM deficiency was significantly greater in CVID (p = 0.0156; Chi-square test).
Table 2: Phenotype Frequencies of HLA-A Alleles in Alabama Subjects.1
A* Phenotypes Frequency in CVID and IgGSD Index 
Patients (n= 240)
Frequency in Control Subjects (n) Significant Uncorrected 
Values of p
Significant Corrected 
Values of p2
01 0.3458 0.3397 (1,319)
02 0.5292 0.5206 (1,310)
03 0.2875 0.2739 (1,318)
11 0.075 0.1136 (1,320)
23 0.0500 0.0375 (1,254)
24 0.300 0.1304 (1,265) < 0.0001 < 0.0016
25 0.0333 0.0297 (1,281)
26 0.0500 0.0634 (1,278)
28 0.025 0.0773 (1,320)
29 0.0583 0.0620 (1,290)
30 0.0292 0.0405 (1,308)
31 0.0542 0.0350 (1,258)
32 0.0375 0.0536 (1,232)
33 0.0083 0.0176 (1,248)
34 0.0083 0.0044 (1,146)
66 0.0167 0 (243)
1 Phenotypes were detected using low-resolution DNA-based typing in CVID and IgGSD index patients and microlymphocytotoxcity typing in con-
trol subjects. Because our HLA typing was conducted over a period of several years during which splits of certain alleles had not been defined, we 
collapsed the phenotype HLA-A*10 into HLA-A*26 and the phenotype HLA-A*68 into HLA-A*28 to facilitate the present comparisons. 2These val-
ues were corrected using the Bonferroni inequality method.BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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significantly greater frequency in index cases (0.3000
index cases vs. 0.1304 controls; p < 0.0001 "uncorrected"
and p < 0.0016 "corrected"). There were no other signifi-
cant differences in HLA-A phenotype frequencies between
these groups (Table 2).
Thirty-two B phenotypes were detected in 240 index cases
(Table 3). Thirty B phenotypes were detected in control
subjects. The most frequent B phenotypes in index cases
were B*44 (0.3167), B*07 (0.2667), and B*08 (0.2583).
The most frequent B alleles in controls were B*44
(0.2866), B*08 (0.2487), and B*07 (0.2259). The fre-
quencies of B*14, B*15, B*35, B*40, B*49, and B*50
were significantly greater in index cases based on "uncor-
rected" values of p (Table 3). The frequencies of B*14 and
B*40 were significantly greater in index cases based on
"corrected" values of p (Table 3). The frequencies of B*58
and B*62 were significantly lower in index cases based on
"uncorrected" values of p  (Table 3). The frequency of
B*62 was significantly lower in index cases based on a
"corrected" value of p (Table 3).
Frequencies of HLA-A and -B Haplotypes
Data were available that permitted frequency compari-
sons to be made between index cases and probands for 85
haplotypes. The most frequent haplotypes in index cases
were A*02-B*44 (frequency 0.1385), A*01-B*08 (fre-
quency 0.1308), and A*03-B*07 (frequency 0.1000)
(Table 4). Each of these haplotypes was significantly more
frequent in index cases than in control subjects
("uncorrected" values of p < 0.0001, 0.0252, and 0.0011,
respectively) (Table 4). After performing the Bonferroni
corrections, the frequency of A*02-B*44 alone was signif-
icantly increased in probands (p  < 0.0085) (Table 4).
Table 3: Phenotype Frequencies of HLA-B Alleles in Alabama Subjects.1
B* Phenotypes Frequency in CVID and IgGSD Index 
Patients (n = 240)
Frequency in Control 
Subjects (n)
Significant Uncorrected 
Values of p
Significant Corrected Values of p2
07 0.2667 0.2259 (1,321)
08 0.2583 0.2487 (1,315)
13 0.0250 0.0343 (1,314)
14 0.1167 0.0639 (1,314) 0.0037
15 0.0792 0.0144 (1,320) < 0.0001 < 0.0030
18 0.0708 0.0775 (1,251)
27 0.0708 0.0895 (1,318)
35 0.0917 0.1406 (1,309) 0.0403
37 0.0250 0.0240 (1,167)
38 0.0167 0.0193 (1,194)
39 0.0250 0.0225 (1,198)
40 0.0792 0.0265 (1,321) < 0.0001 < 0.0030
41 0.0167 0.0119 (1,089)
42 0.0042 0.0040 (1,252)
44 0.3167 0.2866 (1,263)
45 0.0083 0.0177 (1,241)
46 0.0042 0 (19)
47 0.0083 0.0039 (513)
48 0.0042 0 (909)
49 0.0417 0.0171 (1,230) 0.0153
50 0.0333 0.0140 (1,212) 0.0414
51 0.1042 0.0696 (1,250)
52 0.0167 0.0180 (1,164)
53 0.0083 0.0077 (1,163)
54 0 0.0058 (1,027 - - -
55 0.0208 0.0259 (1,042)
56 0.0125 0.0097 (928)
57 0.0667 0.0385 (1,014)
58 0.0042 0.0256 (1,014) 0.0228
60 0.0583 0.1206 (1,086)
61 0.0167 0.0173 (980)
62 0.0333 0.1285 (1,175) < 0.0001 < 0.0030
78 0.0042 no data - - -
1 Phenotypes were detected using low-resolution DNA-based typing in CVID and IgGSD patients and microlymphocytotoxcity typing in control 
subjects. 2These values were corrected using the Bonferroni inequality method.BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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Three other haplotypes were also significantly more fre-
quent in index cases based on "uncorrected" values of p.
These were A*03-B*14, A*31-B*40, and A*32-B*14
(Table 4). The combined frequencies of these three latter
haplotypes were 0.0411 in index patients and 0.0126 in
control subjects (p < 0.0002 "uncorrected" and p = 0.0166
"corrected"). Two haplotypes were significantly more fre-
quent in control subjects based on "uncorrected" values of
p. These were A*02-B*60 and A*03-B*44 (Table 4). How-
ever, these differences were no longer significant after cor-
rection using the Bonferroni method. Homozygosity for
these haplotypes was observed in some index cases: A*02-
B*07 (n = 1); A*02-B*44 (n = 4); A*02-B*62 (n = 1); and
A*03-B*07 (n = 2).
Fifty-two of 195 index patients (26.7%) were HLA-haploi-
dentical with at least one other index case in the present
study (Table 5). Forty-eight of these 52 index patients
(92.3%) had the haplotypes A*01-B*08, A*02-B*44, or
A*03-B*07. Altogether, eighteen different haplotypes
defined by A and B typing were observed in these 52 index
cases (Table 5).
Table 4: HLA-A and -B Haplotypes in Alabama Subjects.
HLA-A HLA-B Frequency in 195 CVID and IgGSD 
Index Cases (390 chromosomes)
Frequency in 751 Controls 
(1502 chromosomes)
Significant Uncorrected 
Values of p
Significant Corrected 
Values of p1
01 08 0.1308 0.0925 0.0252
02 44 0.1385 0.0633 < 0.0001 < 0.0085
60 0.0103 0.0233 0.0076
03 07 0.1000 0.0546 0.0011
14 0.0231 0.0113 0.0095
44 0 0.0127 0.0122
31 40 0.0103 0.0013 0.0187
32 14 0.0077 0 0.0087
1 These values were corrected using the Bonferroni inequality method.
Table 5: HLA Haploidentical Alabama Index Cases.1
First Haplotype Second Haplotype Frequency of Haploidentical Index Cases (n)
A*01-B*08 A*02-B*27 0.0154 (3)
A*02-B*44 0.0256 (5)
A*03-B*07 0.0205 (4)
A*23-B*44 0.0103 (2)
A*29-B*44 0.0103 (2)
A*30-B*13 0.0103 (2)
A*32-B*14 0.0103 (2)
A*02-B*07 A*03-B*07 0.0154 (3)
A*02-B*18 A*02-B*44 0.0103 (2)
A*02-B*44 A*02-B*44 0.0205 (4)
A*02-B*60 0.0103 (2)
A*03-B*07 0.0205 (4)
A*03-B*14 0.0103 (2)
A*25-B*18 0.0103 (2)
A*31-B*40 0.0103 (2)
A*03-B*07 A*03-B*07 0.0103 (2)
A*24-B*44 0.0103 (2)
A*29-B*44 0.0154 (3)
A*24-B*07 A*29-B*18 0.0103 (2)
A*24-B*60 A*28-B*60 0.0103 (2)
1 These two-haplotype matches were observed in 52 of 195 Caucasian index patients (26.7%) with CVID or IgGSD (390 chromosomes) who 
resided in central Alabama. Frequencies are expressed as fractions of 195 index cases. Twenty-one patients representing nine different haplotype 
combination occured in CVID cases, seventeen patients representing six different haplotype combinations occurred in IgGSD cases, and another 14 
patients representing seven different haplotype combinations occurred across the the two index patient groups. Evaluation of these data revealed 
that there were no significant differences in the freqencies of the various haplotypes in these groups of 52 CVID and IgGSD index cases.BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
Page 7 of 11
(page number not for citation purposes)
Segregation of HLA Haplotypes with CVID or IgGSD in 
Kinships
We diagnosed CVID or IgGSD in first-degree or other rel-
atives of 26 of 195 index patients for whom HLA-A and -
B haplotypes had been ascertained. These haplotypes seg-
regated with CVID or IgGSD in 24 of the 26 kinships:
A*01-B*08 (10 kinships); A*02-B*08 (1 kinship); A*02-
B*44 (8 kinships) (Fig. 1); A*02-B*50 (1 kinship); A*03-
B*07 (1 kinship); A*11-B*35 (1 kinship); and A*29-
B*44 (2 kinships). In one of the two remaining kinships,
both A*02-B*07 and A*03-B*07 segregated with CVID or
IgGSD (Fig 2.). In the other remaining kinship, one index
patient and her sister had IgGSD but they were HLA-non-
identical. However, each of these women inherited a hap-
lotype significantly associated with CVID and IgGSD
(index patient A*02-B*44 and A*03-B*57; sister A*03-
B*35 and A*23-B*27).
Relationships of HLA Phenotypes and Haplotypes to 
Immunoglobulin Phenotypes
Comparison of HLA-A and -B Phenotype Frequencies in CVID and 
IgGSD
The frequencies of A phenotypes were similar in the CVID
and IgGSD, with the exceptions that HLA-A*24 which
occurred with significantly greater frequency in IgGSD
cases (0.4206 vs. 0.1667 CVID, p = < 0.0001), and that
HLA-A*31 was more frequent in CVID cases (0.0877 vs.
0.0238 IgGSD, p = 0.0277). The frequencies of HLA-B
Pedigree of kinship in which various antibody deficiency phenotypes occurred in association with inheritance of the HLA haplo- type A*02-B*44 Figure 1
Pedigree of kinship in which various antibody deficiency phenotypes occurred in association with inheritance of the HLA haplo-
type A*02-B*44. Index patient indicated by arrow. CVID = common variable immunodeficiency; IgGSD = selective IgG subclass 
deficiency.
52 y.o. with CVID (IgG1, 
IgA deficiencies), 
recurrent sinusitis, 
bronchitis
A*02-B*44
A*28-B*44
78 y.o. with normal IgG, A, 
M, rare infections
A*28-B*44
A*29-B*45
76 y.o. with IgGSD (IgG3
deficiency), rare infections; 
breast cancer
A*02-B*44
A*03-B*62
48 y.o. with CVID 
(IgG1 deficiency), 
recurrent sinusitis, 
bronchitis
A*02-B*44
A*29-B*45
45 y.o. with IgGSD 
(IgG3 deficiency), 
recurrent sinusitis, 
bronchitis
A*02-B*44
A*29-B*45
22 y.o. with IgGSD (IgG4
deficiency), occasional 
sinusitis, bronchitis; lupus
A*02-B*44
A*68-B*37
12 y.o. with normal IgG, A, M, 
rare infections
A*29-B*45
A*68-B*37BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
Page 8 of 11
(page number not for citation purposes)
phenotypes were similar in the two groups, with the
exceptions that B*07 and B*50 occurred with significantly
greater frequencies in IgGSD cases (0.3333 vs. 0.1930
CVID, p = 0.0101; and 0.0635 vs. 0, p = 0.0052, respec-
tively), and that B*55 occurred more frequently in CVID
cases (0.0439 vs. 0 IgGSD, p = 0.0231).
Comparison of Haplotype Frequencies in CVID and IgGSD
The haplotype frequencies in CVID and IgGSD did not
differ significantly, with two exceptions. The frequency of
A*23-B*44 was significantly greater in CVID patients than
in IgGSD patients (0.0263 vs. 0, respectively, p = 0.0267).
The frequency of A*24-B*35 was greater in patients with
IgGSD than in patients with CVID (0.0250 vs. 0, respec-
tively, p = 0.0346).
Possible Dose Effect of Haplotype on Total Serum Immunoglobulin 
Concentrations
Eleven haplotypes occurred with significantly greater fre-
quency in index patients with CVID and IgGSD than in
control subjects (described above). Mean values of serum
IgG, IgA, or IgM did not vary significantly according to the
inheritance of 0, 1, or 2 of these eleven haplotypes (Table
6). Similarly, some index patients in each pattern of IgG
subclass deficiency were positive for one or two of these
eleven haplotypes, with the exception of the sole index
Pedigree of kinship in which various antibody deficiency phenotypes occurred in association with inheritance of the HLA haplo- types A*02-B*07 and A*03-B*07 Figure 2
Pedigree of kinship in which various antibody deficiency phenotypes occurred in association with inheritance of the HLA haplo-
types A*02-B*07 and A*03-B*07. Index patient indicated by arrow. Deduced haplotypes displayed in parentheses. CVID = 
common variable immunodeficiency; IgGSD = selective IgG subclass deficiency.
54 y.o. with CVID (IgG1, IgG3, and IgG4
deficiencies; IgM deficiency), recurrent sinusitis, 
pneumonia; adult respiratory distress syndrome
A*02-B*07
A*03-B*07
21 y.o with IgGSD (IgG3
deficiency), recurrent 
sinusitis
A*03-B*07
A*69-B*41
(A*69-B*41)
28 y.o with 
recurrent sinusitis
78 y.o. with CVID (IgG1, IgG3
deficiencies), recurrent sinusitis; 
breast cancer
A*02 -B*07
A*29-B*39
Crohn disease
(A*03-B*07)BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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patient with deficiencies of IgG1, IgG2, and IgG4 who did
not have any of these twelve haplotypes.
Frequencies of Index Patients with HLA Haplotype A*01-B*08
Some reports suggest that IgA deficiency segregates with a
HLA haplotype(s) containing A*01, B*08 in some fami-
lies [4–6,19,20]. Thus, we analyzed the frequencies of the
haplotype A*01-B*08 in the present index patients
grouped according to presence of normal or subnormal
pre-treatment serum concentrations of IgG, IgA, and IgM,
respectively. Although frequencies of positivity for A*01-
B*08 were slightly greater in index patients who had defi-
ciencies of IgG, IgA, or IgM, these differences were not sig-
nificant (Table 7). There were insufficient numbers of
index patients homozygous for A*01-B*08 to estimate
the effect of homozygosity for this haplotype on serum
immunoglobulin concentrations.
Disparity of Immunoglobulin Phenotype in Family Members with 
Same HLA Haplotype
In some kinships, different immunoglobulin deficiency
phenotypes were observed among family members with
CVID or IgGSD who shared HLA-A and -B haplotypes.
One representative pedigree demonstrating these
disparities between immunoglobulin phenotype, fre-
quency of infections, and HLA haplotype is displayed in
Figure 1. In a second kinship, two different haplotypes
segregated with antibody deficiency, although the immu-
noglobulin deficiency pattern was different in each of
three affected family members (Fig. 2). One pair of
monozygotic twins was available for evaluation. The
index patient had IgGSD (IgG3 subclass deficiency; HLA-
A24, 25;- B15, 49) and recurrent upper and lower respira-
tory tract infections. Her twin had normal serum concen-
trations of total IgG, IgG subclasses, IgA, and IgM, and did
not report increased frequency or severity of infections.
Estimation of Population Frequency of CVID and IgGSD
The occurrence of CVID and IgGSD in spouses of the
present index cases permitted us to estimate the combined
population frequency of CVID and IgGSD in adults. At the
time of diagnosis, 217 of the present 240 index cases had
spouses. Of these 217 spouses, we diagnosed CVID in one
and IgGSD in another because they also had increased fre-
quency and severity of bacterial infections, predominantly
those of the upper and lower respiratory tracts. Thus, a
conservative estimate of the combined frequencies of
these disorders in adults in central Alabama is 0.0092 (2/
217).
Discussion
The present observations demonstrate that CVID and
IgGSD in Caucasian adults diagnosed in routine medical
care delivery are significantly associated with HLA haplo-
types on Ch6p. More than two-thirds of the present 195
index patients who were evaluable for haplotyping inher-
ited one or two of the significantly associated haplotypes
A*01-B*08, A*02-B*44, A*03-B*07, A*03-B*14, A*31-
B*40, and A*32-B*14. This indicates that a susceptibility
locus (loci) for CVID and IgGSD occurs on multiple hap-
Table 6: Serum Immunoglobulin Concentrations in Index Patients with Significantly Associated HLA-A and -B Haplotypes.1
Number of Significantly Associated Haplotypes 0 1 2
Serum IgG, mg/dL (n) 734 ± 273 (45) 735 ± 287 (112) 749 ± 257 (33)
Serum IgA, mg/dL (n) 167 ± 92 (48) 157 ± 117 (109) 169 ± 71 (33)
Serum IgM, mg/dL (n) 108 ± 70 (46) 116 ± 96 (110) 115 ± 108 (34)
1 These data are expressed as mean ± 1 SD. Significantly associated haplotypes were defined as those that occurred with significantly greater fre-
quency in CVID and IgGSD index cases than in control subjects. These six haplotypes were: A*01-B*08, A*02-B*44, A*03-B*07, A*03-B*14, A*31-
B*40, and A*32-B*14 (see Table 4). There were no significant differences in the mean values of IgG, IgA, or IgM in the index patients grouped by 
inheritance of significantly associated haplotypes.
Table 7: CVID and IgGSD Index Cases Positive for Haplotype A*01-B*08.1
Serum Immunoglobulin Concentrations Total IgG Concentration, frequency in 
195 Index Cases (fraction)
IgA Concentration, frequency in 195 
Index Cases (fraction)
IgM Concentration, frequency in 195 
Index Cases (fraction)
No Deficiency2 0.23 (23/100) 0.24 (39/162) 0.24 (41/169)
Deficiency2 0.27 (26/95) 0.30 (10/33) 0.31 (8/26)
1 Comparisons of positivity for HLA haplotype A*01-B*08 revealed no significant differences (Chi-square analysis) in index cases grouped by serum 
total IgG, IgA, and IgM concentration, respectively. 2 Deficiency of an immunoglobulin class was defined by a serum concentration at diagnosis that 
was less than the corresponding lower reference limit.BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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lotypes defined by HLA-A and -B typing. Further, this
implies that putative Ch6p alleles associated with CVID or
IgGSD susceptibility occur on many HLA haplotypes that
are common in Caucasians in central Alabama [10] and in
Caucasians from a large national bone marrow donor pro-
gram [14]. The present observations also confirm and
extend the reports of association of HLA haplotype A*01-
B*08 (or an extended haplotype containing A*01 and
B*08) with heritable forms of immunoglobulin defi-
ciency demonstrated in family-based analyses [3,6,19–
22]. It is likely that a candidate gene(s) for CVID or IgGSD
exists in the HLA class II region, [6,19–23]. Because the
class II region is closer to the HLA-B locus than to the
HLA-A locus, it is plausible that candidate gene(s) for
CVID or IgGSD in the class II region are in greater linkage
disequilibrium with HLA-B than HLA-A. This is consistent
with the aggregate observations on HLA-A and -B typing
in the present study.
The present observations demonstrate that the frequen-
cies of HLA-A and -B phenotypes and haplotypes were not
significantly different in CVID and IgGSD index patients,
with few exceptions. These observations could be
explained by the occurrence of an HLA-linked allele that
is necessary to cause either CVID or IgGSD, but is insuffi-
cient to induce a specific immunoglobulin deficiency phe-
notype. Alternatively, the variable immunoglobulin
deficiency phenotypes presently classified as CVID and
IgGSD are best explained by the co-inheritance of multi-
ple alleles, each of which has an independent effect on the
immunoglobulin deficiency phenotype. Regardless, the
variability we observed in IgG, IgA, and IgM phenotypes
in index patients and family members is best explained by
the co-inheritance of multiple allele(s) that influence the
immunoglobulin phenotype. This is consistent with evi-
dence for the occurrence on Ch6p of multiple distinct sus-
ceptibility genes for patterns of immunoglobulin
deficiency, some recessive and others dominant [20]. For
example, at least two putative alleles associated with her-
itable IgA deficiency occur on Ch6p, and each is associ-
ated with a different major histocompatibility (MHC)
region haplotype [22,23], whereas a putative susceptibil-
ity locus on chromosome 18 is not a major contributor to
selective IgA deficiency [24]. Allele(s) on chromosomes
other than Ch6p may also influence the phenotypic
expression of CVID and IgGSD in adults. The inheritance
of certain polymorphisms of the mannose-binding lectin
gene on Ch10 in persons with CVID are associated with
earlier age of onset of manifestations of antibody defi-
ciency and with increased risk of autoimmunity [25].
Altogether, these observations are consistent with the
hypothesis that many common heritable antibody defi-
ciency phenotypes collectively diagnosed as CVID or
IgGSD are the result of the inheritance of multiple disease-
predisposing alleles on Ch6p and possibly other
chromosomes.
We have estimated that the prevalence of CVID and
IgGSD in adults in central Alabama is 0.0092. This esti-
mated prevalence could be reasonably attributed to the
fact that many of the HLA haplotypes significantly associ-
ated with CVID and IgGSD are also common in the
general population. This could also explain a) the inherit-
ance of two significantly associated HLA haplotypes in
many of the present index cases, including most of the
index patients who were HLA-haploidentical with at least
one other index patient; b) the disparate immunoglobulin
deficiency phenotypes of multiple family members who
inherited the same HLA haplotype; and c) the occurrence
of disparate haplotypes in two sisters who had similar
immunoglobulin phenotypes.
Some of the haplotypes significantly associated with
CVID and IgGSD in the present study also occur with
significantly increased frequencies in central Alabama
Caucasian hemochromatosis probands with homozygos-
ity for HFE C282Y on Ch6p [10]. These haplotypes are
A*03-B*07 and A*03-B*14 [[10]; present study]. These
observations imply that susceptibility alleles for CVID and
IgGSD occur on haplotypes that sometimes include the
HFE C282Y allele. In addition, the haplotypes A*01-B*08
and A*02-B*44 significantly associated with CVID and
IgGSD in the present study are common in both hemo-
chromatosis probands homozygous for HFE C282Y and
control subjects in Alabama [[10]; present study]. Taken
together, these observations could explain the occurrence
of CVID or IgGSD and hemochromatosis due to HFE
C282Y homozygosity in some of the present index
patients [26] and account for the occurrence of IgA defi-
ciency and hemochromatosis in different members of the
same family [27].
Conclusions
CVID and IgGSD are significantly associated with the HLA
haplotypes A*01-B*08, A*02-B*44, A*03-B*07, A*03-
B*14, A*31-B*40, and A*32-B*14. Many of these haplo-
types are also common in the Alabama Caucasian popu-
lation. Immunoglobulin phenotype variability
demonstrated in index cases and in family studies suggest
that there are multiple gene(s) on Ch6p or other chromo-
somes that modify the immunoglobulin phenotypes of
CVID and IgGSD. The estimated prevalence of these disor-
ders in central Alabama is 0.0092. The estimated preva-
lence of CVID and IgGSD in central Alabama could be
reasonably attributed to the fact that many HLA
haplotypes significantly associated with these disorders
are also common in the general population.BMC Medical Genetics 2003, 4 http://www.biomedcentral.com/1471-2350/4/3
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